Leopiras, Kathleen .

HRN: 20-08-19  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2026
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
01/03/2026
01/09/2026
ORAL
3ml
Q12
UTI
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: